Comprehensive identification of a migrasomes-associated long non-coding RNA signature to predict the prognosis and treatment options in colon adenocarcinoma

Abstract Background Migrasomes, recently discovered cellular substructures, may play a crucial role in cancer progression, treatment response, and prognosis. However, the prognostic value of migrasome-associated long non-coding RNAs (lncRNAs) in colon adenocarcinoma (COAD) remains unexplored. Method...

Full description

Bibliographic Details
Published in:	Discover Oncology
Main Authors:	Zhen Zheng, Hui Liu, Quan Xu, Wei Cui, Kaitai Liu
Format:	Article
Language:	English
Published:	Springer 2025-03-01
Subjects:	Colon adenocarcinoma Migrasomes lncRNA Tumor-infiltrating immune Tumor mutation burden
Online Access:	https://doi.org/10.1007/s12672-025-02197-9

Similar Items

Construction and validation of a prognostic model for colorectal cancer based on migrasome-related long non-coding RNAs
by: Qiang Lv, et al.
Published: (2025-05-01)

Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma
by: Weijie Xue, et al.
Published: (2023-09-01)

Metabolism‐related lncRNAs signature to predict the prognosis of colon adenocarcinoma
by: Yimin Sun, et al.
Published: (2023-03-01)

Influence of migrasome-associated long noncoding RNAs on the immune microenvironment and prognosis in lung adenocarcinoma
by: Hui Zhao, et al.
Published: (2025-06-01)

Identification of PANoptosis associated lncRNAs associated with clinical prognosis and immune infiltration microenvironment in colon adenocarcinoma
by: Yangyang Wang, et al.
Published: (2025-01-01)

N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients
by: Peiling Zhang, et al.
Published: (2021-07-01)

The roles of migrasome in development
by: Zhaocheng Zhai, et al.
Published: (2024-02-01)

Construction of a risk and prognostic model for migrasome-associated lncRNAs in renal cell carcinoma
by: Liangwei Zhao, et al.
Published: (2025-07-01)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma
by: Ying Guo, et al.
Published: (2023-07-01)

Integrative bulk and single-cell transcriptomic analysis identifies a migrasome-associated lncRNA signature predictive of prognosis and immune landscape in clear cell renal cell carcinoma
by: Junlin Shen, et al.
Published: (2025-08-01)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
by: Chong Li, et al.
Published: (2023-06-01)

A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma
by: Chao Ma, et al.
Published: (2023-08-01)

In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma
by: Yue Wang, et al.
Published: (2022-09-01)

Integration analysis for novel lncRNA markers predicting tumor recurrence in human colon adenocarcinoma
by: Fangyao Chen, et al.
Published: (2019-08-01)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
by: Pengpeng Zhang, et al.
Published: (2023-01-01)

Novel insights into the roles of migrasome in cancer
by: Sijun Deng, et al.
Published: (2024-05-01)

A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma
by: Zipei Song, et al.
Published: (2024-02-01)

Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma
by: Miaorong Xu, et al.
Published: (2022-07-01)

Migrasome-Related Genes as Potential Prognosis and Immunotherapy Response Predictors for Colorectal Cancer
by: Lu Chang, et al.
Published: (2025-03-01)

A novel sphingolipid metabolism-related long noncoding RNA signature predicts the prognosis, immune landscape and therapeutic response in pancreatic adenocarcinoma
by: Xiaolan He, et al.
Published: (2024-01-01)

Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment
by: Yuanyong Wang, et al.
Published: (2022-08-01)

TSPAN4+ fibroblasts coordinate metastatic niche assembly through migrasome-driven metabolic reprogramming and stromal-immune crosstalk in pancreatic adenocarcinoma
by: Qingwen Hu, et al.
Published: (2025-05-01)

5mC-Related lncRNAs as Potential Prognostic Biomarkers in Colon Adenocarcinoma
by: Yinghui Huang, et al.
Published: (2022-02-01)

A novel prognostic signature based on N7-methylguanosine-related long non-coding RNAs in breast cancer
by: Zhidong Huang, et al.
Published: (2022-10-01)

A Prognostic Model for Senescence-Related LncRNA in a Novel Colon Adenocarcinoma Based on WGCNA and LASSO Regression
by: Yichu Huang, et al.
Published: (2025-04-01)

Migrasomes and tetraspanins in hepatocellular carcinoma: current status and future prospects
by: Zhongqi Zhang, et al.
Published: (2023-10-01)

Migrasome, a novel organelle, differs from exosomes
by: Xun Tan, et al.
Published: (2023-09-01)

CLEC11A as a potential biomarker for prognosis and response to immunotherapy in colon adenocarcinoma
by: Yuyang Gu, et al.
Published: (2025-09-01)

Identification of a long non-coding RNA signature associated with cuproptosis for prognosis and immunotherapy response prediction in patients with lung adenocarcinoma
by: Jie Zeng, et al.
Published: (2025-03-01)

Development and validation of a novel risk stratification signature derived from migrasome and tumor microenvironment-related genes for molecular subtyping and improving clinical outcomes in head and neck squamous cell carcinoma
by: Huifang Chai, et al.
Published: (2025-12-01)

A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma
by: Zhaoxiang Song, et al.
Published: (2023-12-01)

Exploring and validating the necroptotic gene regulation and related lncRNA mechanisms in colon adenocarcinoma based on multi-dimensional data
by: Weili Wang, et al.
Published: (2024-09-01)

M6A-Related Long Non-Coding RNA Displays Utility in Predicting Prognosis, Portraying the Tumor Immune Microenvironment and Guiding Immunotherapy in Pancreatic Ductal Adenocarcinoma
by: Guangyu Xu, et al.
Published: (2023-02-01)

Migrasomes, a new mode of intercellular communication
by: Yuyun Jiang, et al.
Published: (2023-05-01)

Over-Expression of Long Non-Coding RNA-AC099850.3 Correlates With Tumor Progression and Poor Prognosis in Lung Adenocarcinoma
by: Xi Chen, et al.
Published: (2022-05-01)

The immunosurveillance signature predicts the prognosis and immunotherapy sensitivity for colon adenocarcinoma
by: Yan Xiong, et al.
Published: (2025-06-01)

Migrasomes: A New Role in Disease Diagnosis and Treatment
by: Zhang X, et al.
Published: (2025-10-01)

An anoikis-related lncRNA signature is a useful tool for predicting the prognosis of patients with lung adenocarcinoma
by: Xin Jiang, et al.
Published: (2023-11-01)

Correction: Over-expression of long non-coding RNA-AC099850.3 correlates with tumor progression and poor prognosis in lung adenocarcinoma
by: Xi Chen, et al.
Published: (2025-07-01)

Comprehensive analysis of mitochondrial-related gene signature for prognosis, tumor immune microenvironment evaluation, and candidate drug development in colon cancer
by: Hao Wu, et al.
Published: (2025-02-01)